301122.SZ
采纳股份
SZSE · Healthcare · C 制造业 · CN
CNY 39.00
−1.27%Year over year
Reported trailing growth
- Revenue
- +21.5%
- EBITDA
- —
- EBIT
- -85.0%
- EPS
- -68.4%
- Free cash flow
- -56.6%
- Operating cash flow
- -83.9%
Forward estimates
Based on analyst estimates
- Revenue
- -69.5%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -8.5%
- EBITDA
- -36.0%
- EBIT
- -77.6%
- Net income
- -67.4%
- EPS
- -69.5%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026